Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lux Biosciences

Request full access

Luxury fashion and jewelry news, tips, and exclusive insights for the discerning shopper

Jersey City, United StatesFounded 2005Real Estate

About Lux Biosciences

LuxBio operates in the luxury fashion and jewelry market, providing curated news, tips, and exclusive insights to fashion enthusiasts and high-end shoppers. The company serves a clientele that values elegance, style, and exclusivity, offering a range of content that includes fashion advice, quotes, and the latest trends. LuxBio's business model revolves around generating revenue through advertising, affiliate marketing, and premium content subscriptions. By leveraging its expertise and extensive knowledge in the luxury sector, LuxBio aims to deliver a unique and enriching experience to its audience. The company stands out by combining high-quality content with a deep understanding of luxury fashion, making it a go-to resource for those looking to stay ahead in the fashion world.

Source: Dealroom company data

At a glance

Status
Closed
Founded
2005
Headquarters
Jersey City, United States
Open positions
None listed
Industry
Real Estate
Sector
Real Estate, Biotechnology
Client focus
B2B

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Mar 2012 $16M — Undisclosed —
DEBT✓Debt Dec 2011 $4M — Undisclosed —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Lux Biosciences website traffic

Latest recorded traffic for Lux Biosciences is 0 monthly website visits.

Latest monthly visits0
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Lux Biosciences in the Jersey City ecosystem

Live from Dealroom

The Lux Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Novo Holdings
  • Prospect Venture Partners
  • SV Health Investors

Other known investors1 additional known investor

  • International Life Sciences Institute Research Foundation
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Jersey City HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Lux Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lux Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.